Internal Medicine, Hematology & Oncology · Huntington, WV
NPI
1922207117
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
3075 US Route 60 Ste B405
Huntington, WV, 25705
Phone (304) 528-4600
Groups this clinician bills Medicare through
Medicare paid, 2024
$145K
2,604 services
Medicare patients, 2024
499
Average age 74
Drug cost, 2024
$5.3M
2,408 prescriptions
Company payments, 2025
$61K
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Damian Silbermins was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 995 times for 308 patients. In total Damian Silbermins billed 2,604 services in 14 codes, and Medicare paid $145K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-01.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 995 | 308 | $12.73 | $13K |
| 99214 Office E&M - Established | Office | 671 | 252 | $71.58 | $48K |
| 99215 Office E&M - Established | Office | 294 | 123 | $109.66 | $32K |
| 99213 Office E&M - Established | Office | 204 | 158 | $46.35 | $9,456 |
| 99223 Hospital E&M - Initial | Facility | 149 | 137 | $131.48 | $20K |
| 99232 Hospital E&M - Subsequent | Facility | 126 | 79 | $61.74 | $7,780 |
| 99233 Hospital E&M - Subsequent | Facility | 70 | 48 | $92.62 | $6,483 |
| 99205 Office E&M - New | Office | 35 | 35 | $136.14 | $4,765 |
| 99231 Hospital E&M - Subsequent | Facility | 27 | 23 | $38.45 | $1,038 |
| 99204 Office E&M - New | Office | 25 | 25 | $87.27 | $2,182 |
By year: 2022 $130K for 1,714 services; 2023 $130K for 1,711 services; 2024 $145K for 2,604 services.
Medicare prescription drug claims, 2024
In 2024, the drug Damian Silbermins prescribed most often to Medicare patients was Eliquis (Apixaban), with 210 prescriptions and refills. In total Damian Silbermins wrote 2,408 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 210 | 423 | 62 | $241K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 133 | 133 | 34 | $2,491 |
| Anastrozole Generic | 127 | 349 | 37 | $2,123 |
| Prednisone Generic | 81 | 87 | 41 | $237 |
| Ondansetron Hcl Generic | 75 | 75 | 45 | $1,108 |
| Gabapentin Generic | 58 | 80 | Under 11 | $957 |
| Prochlorperazine Maleate Generic | 57 | 57 | 43 | $1,129 |
| Hydroxyurea Generic | 56 | 122 | 12 | $1,183 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 54 | 54 | 37 | $646 |
| Brukinsa Zanubrutinib | 52 | 52 | Under 11 | $689K |
| Potassium Chloride Generic | 51 | 83 | 17 | $863 |
| Dexamethasone Generic | 51 | 51 | 23 | $601 |
| Xarelto Rivaroxaban | 50 | 88 | 16 | $46K |
| Letrozole Generic | 48 | 112 | 13 | $1,704 |
| Acyclovir Generic | 46 | 106 | 17 | $933 |
Brand drugs: - claims; generic drugs: 1,811 claims; opioid claims: 271.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Damian Silbermins $61K ($61K in general payments such as food, travel and fees) from 34 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $41K.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 29 | $41K |
| Jazz Pharmaceuticals Inc. JAZZ | 14 | $9,623 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $3,441 |
| BeOne Medicines USA, Inc. ONC | 6 | $2,058 |
| Janssen Biotech, Inc. JNJ | 12 | $1,422 |
| Incyte Corporation INCY | 6 | $1,397 |
| Novartis Pharmaceuticals Corporation NVS | 20 | $735 |
| Pfizer Inc. PFE | 11 | $212 |
| Daiichi Sankyo Inc. 4568.T | 16 | $207 |
| Merck Sharp & Dohme LLC MRK | 7 | $147 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.